FOLD
AMICUS THERAPEUTICS, INC.
Key Financials
Operating Income
$32.8M
↑ 31.8%
Net Income
$-27110000
↑ 51.7%
Gross Profit
$561.3M
↑ 18.1%
Revenue
$634.2M
↑ 20.0%
Cash & Equivalents
$214.0M
↑ 0.1%
Total Assets
$949.9M
↑ 21.0%
EPS (Diluted)
$-0.09
↑ 50.0%
Shareholders' Equity
$274.2M
↑ 41.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | FOLD |
| Company Name | AMICUS THERAPEUTICS, INC. |
| CIK | 1178879 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (609) 662-2000 |